Research Funding

  • Transformative Research to Address Health Disparities and Advance Health Equity

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) 4/27/2022 RFA-RM-22-021 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
Letter of Intent:
8/2/2022
Receipt Date:
9/2/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional) 4/7/2022 RFA-RM-22-019 Patricia (Trish) Labosky

NewInnovatorAwards@mail.nih.gov

301-594-4863
Receipt date:
8/19/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2023 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) 4/13/2022 RFA-RM-22-018 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
9/9/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) 5/12/2022 RFA-RM-22-020 Ravi Basavappa
Transformative_Awards@mail.nih.gov (link sends e-mail)
(301) 435-7204
9/1/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

Illuminating the Druggable Genome Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) 4/15/2022 RFA-RM-22-024 Karlie Sharma
DruggableGenome@mail.nih.gov
301-451-4965
Letter of Intent:
6/15/2022
Receipt Date:
7/15/2022

Somatic Cell Genome Editing (SCGE) Program

Title NIH Guide RFA Number NIH Contact Receipt Date
Somatic Cell Genome Editing Translational Coordination and Dissemination Center (U24, Clinical Trial Not Allowed) 4/11/2022 RFA-RM-22-017 Marrah Lachowicz-Scroggins
marrah.lachowicz-scroggins@nih.gov
301-827-8229
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022
Platform Clinical Trials of Somatic Genome Editing for Multiple Diseases (UG3/UH3, Clinical Trial Required) 4/11/2022 RFA-RM-22-016 P.J. Brooks
pj.brooks@mail.nih.gov
301-443-0513
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022
IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed) 4/11/2022 RFA-RM-22-015 Chris Boshoff
chris.boshoff@nih.gov
301-496-1779
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) 4/11/2022 RFA-RM-22-014 Betty Poon
poonb@mail.nih.gov
240-669-5024
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022

Transformative Research to Address Health Disparities and Advance Health Equity

Title NIH Guide RFA Number NIH Contact Estimated Receipt Date
Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
 
5/18/2022 RFA-RM-22-001 Cheryl Anne Boyce
CFHealthDisparities@nih.gov
301-496-0667
Yvonne Ferguson
CFHealthDisparities@nih.gov
301-827-7136
Letter of Intent:
4/22/2022
Receipt Date:
5/23/2022

Somatic Mosaicism across Human Tissues (SMaHT)

Title NIH Guide RFA Number NIH Contact Estimated Receipt Date
Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-009
Jill A. Morris
SMaHT@mail.nih.gov
301-496-5745
Letters of Intent:
06/08/2022
Receipt Date:
07/08/2022

 
Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-010 Amy C. Lossie
SMaHT@mail.nih.gov
301-827-6092
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022
Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-011 Jill Morris
SMaHT@mail.nih.gov
301-496-5754
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022
Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-012 Geetha Senthil
SMaHT@mail.nih.gov
301-402-0754
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022
Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-013 Amy C. Lossie
SMaHT@mail.nih.gov
301-827-6092
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022

NIH Faculty Institutional Recruitment for Sustainable Transformation

Title NIH Guide RFA Number NIH Contact Estimated Receipt Date

NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)

 

02/17/2022 RFA-RM-22-008 Jessica M. Calzola
FIRSTNIH@nih.gov
240-276-7474

Letter of Intent
30 days prior to the application due date

Receipt Date:
07/12/2022

Gabriella Miller Kids First Pediatric Research Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)

11/17/2021 RFA-RM-22-006 James Coulombe
coulombej@mail.nih.gov
301-451-1390
Letter of Intent:
5/10/2022
Receipt Date:
6/10/2022

 

Past Funding Opportunities

 

 

This page last reviewed on May 12, 2022